Association of Inadvertent 9-Valent Human Papillomavirus Vaccine in Pregnancy With Spontaneous Abortion and Adverse Birth Outcomes-Reference-Cited by-同舟云学术

Association of Inadvertent 9-Valent Human Papillomavirus Vaccine in Pregnancy With Spontaneous Abortion and Adverse Birth Outcomes

Published:2021-04-05 Issue:4 Volume:4 Page:e214340
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Kharbanda Elyse O.¹,Vazquez-Benitez Gabriela¹,DeSilva Malini B.¹,Naleway Allison L.²,Klein Nicola P.³,Hechter Rulin C.⁴,Glanz Jason M.⁵,Donahue James G.⁶,Jackson Lisa A.⁷,Sheth Sangini S.⁸,Greenberg Victoria⁸,Panagiotakopoulos Lakshmi⁹,Mba-Jonas Adamma¹⁰,Lipkind Heather S.⁸

Affiliation:

1. Department of Research, HealthPartners Institute, Minneapolis, Minnesota

2. The Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon

3. The Vaccine Study Center, Kaiser Permanente Northern California, Oakland, California

4. Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California

5. Institute for Health Research, Kaiser Permanente Colorado, Denver, Colorado

6. Marshfield Clinic Research Institute, Marshfield, Wisconsin

7. Kaiser Permanente Washington, Health Research Institute, Seattle, Washington

8. Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale University School of Medicine, New Haven, Connecticut

9. Centers for Disease Control and Prevention, Atlanta, Georgia

10. Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, Division of Epidemiology, US Food and Drug Administration, Silver Spring, Maryland

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2778151/kharbanda_2021_oi_210157_1616768661.2131.pdf

Reference35 articles.

1. Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).;Markowitz;MMWR Recomm Rep,2007

2. Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices.;Petrosky;MMWR Morb Mortal Wkly Rep,2015

3. Ten years of human papillomavirus vaccination in the United States.;Markowitz;Acad Pediatr,2018

4. A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women.;Joura;N Engl J Med,2015

5. Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial.;Huh;Lancet,2017

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Does HPV vaccination during periconceptional or gestational period increase the risk of adverse pregnancy outcomes?—An updated systematic review and meta‐analysis based on timing of vaccination;Acta Obstetricia et Gynecologica Scandinavica;2024-08-06

2. Laparoscopic surgery for ectopic pregnancy: A comparative study on the clinical benefits and impact on tubal patency and reproductive outcomes;Technology and Health Care;2024-07-12

3. Defining and reporting adverse events of special interest in comparative maternal vaccine studies: a systematic review;Vaccine: X;2024-06

4. Strategies for Improving Vaccine Communication and Uptake;Pediatrics;2024-02-26

5. Infekce lidským papilomavirem (HPV) a gravidita;Epidemiologie, mikrobiologie, imunologie;2024